Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study

Bibliographic Details
Main Authors:	Dong, Qian, Yang, Xiang-hong, Zhang, Yao, Jing, Wei, Zheng, Li-qiang, Liu, Yun-peng, Qu, Xiu-juan
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064278/

Similar Items

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017-05-01)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
by: Yang, Jian-Yu, et al.
Published: (2015)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
by: Yang, Jian-Yu, et al.
Published: (2015)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
by: Saukkonen, Kapo, et al.
Published: (2015)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
by: Chen, Tao, et al.
Published: (2015)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
by: Joni Leppänen, et al.
Published: (2018-07-01)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
by: Wu, Huanwen, et al.
Published: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
by: Flis Vojko, et al.
Published: (2016-09-01)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
by: Flis, Vojko, et al.
Published: (2016)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
by: Ormanns, Steffen, et al.
Published: (2015)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
by: Chen, Yu-Ling, et al.
Published: (2013)

Clinical Predictors of Resectability of Pancreatic Adenocarcinoma
by: Almadi, Majid A., et al.
Published: (2013)

Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
by: Chen, Ru, et al.
Published: (2014)

High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinoma
by: Zhang, Lingfu, et al.
Published: (2016)

Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy
by: Liu, Peng, et al.
Published: (2015)

Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future
by: Goel, Gaurav, et al.
Published: (2015)

Pancreatic ductal adenocarcinoma staging
by: Al-Hawary, Mahmoud M., et al.
Published: (2013)

Mimics of pancreatic ductal adenocarcinoma
by: Al-Hawary, Mahmoud M., et al.
Published: (2013)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Jiang, Hui, et al.
Published: (2013)

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
by: Distler, Marius, et al.
Published: (2013)

Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
by: Zhang, Jianli, et al.
Published: (2014)

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
by: Dal Molin, Marco, et al.
Published: (2016)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
by: Buc, Emmanuel, et al.
Published: (2014)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
by: Salmiheimo, Aino, et al.
Published: (2016)

Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis
by: Xiao, Wenbin, et al.
Published: (2014)

Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
by: Zong, Meijuan, et al.
Published: (2011)

High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
by: Huo, Yanmiao, et al.
Published: (2015)

High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
by: Huang, Jianfei, et al.
Published: (2015)

Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma
by: Hang, Junjie, et al.
Published: (2016)

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
by: Zhang, Luan-Jing, et al.
Published: (2014)

Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
by: Wang, Li, et al.
Published: (2016)

Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
by: Osayi, Sylvester N., et al.
Published: (2014)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
by: Ottenhof, Niki A., et al.
Published: (2011)

Mast cells in pancreatic ductal adenocarcinoma
by: Chang, David Z.
Published: (2012)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
by: Li, Junjie, et al.
Published: (2016)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Pezzilli, Raffaele, et al.
Published: (2011)

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
by: Hori, Mika, et al.
Published: (2014)

Parasympathetic neurogenesis is strongly associated with tumor budding and correlates with an adverse prognosis in pancreatic ductal adenocarcinoma
by: Zhang, Lingfu, et al.
Published: (2016)

G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma
by: Zhang L, et al.
Published: (2018-08-01)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
by: Li, Ping, et al.
Published: (2016)